Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gentamicin + clindamycin is an antibiotic combination being evaluated as an intraoperative irrigation solution during laparoscopic appendectomy for pediatric patients with perforated appendicitis. Gentamicin is an aminoglycoside antibiotic that primarily targets Gram-negative bacteria by binding to the 30S ribosomal subunit, thereby inhibiting protein synthesis. Clindamycin is a lincosamide antibiotic that targets Gram-positive and anaerobic bacteria by binding to the 50S ribosomal subunit. This combination is used as a local rinse to reduce the bacterial load within the peritoneal cavity and at the surgical site, with the goal of decreasing the incidence of postoperative wound infections and intra-abdominal abscesses (IAA).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gentamicin + clindamycin.